New advance of the molecular targeting agents in advanced non-small cell lung cancer.
- Author:
Li ZHANG
1
;
Zhong-wei CHENG
;
Jin-ming GAO
Author Information
1. Department of Respiratory Disease, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Angiogenesis Inhibitors;
therapeutic use;
Antibodies, Monoclonal;
therapeutic use;
Antineoplastic Agents;
therapeutic use;
Carcinoma, Non-Small-Cell Lung;
drug therapy;
Erlotinib Hydrochloride;
Humans;
Lung Neoplasms;
drug therapy;
Protein-Tyrosine Kinases;
antagonists & inhibitors;
Quinazolines;
therapeutic use;
Receptor, Epidermal Growth Factor;
antagonists & inhibitors
- From:
Acta Academiae Medicinae Sinicae
2004;26(3):323-329
- CountryChina
- Language:Chinese
-
Abstract:
Molecule-targeting agents inhibit the proliferation of tumor cells by the molecular biological differences between tumor cells and normal cells, and finally kill tumor cells. This article introduces several molecule-targeting agents that are currently under clinical trials now.
